These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 11480845

  • 1. Benefits of leflunomide in systemic lupus erythematosus: a pilot observational study.
    Remer CF, Weisman MH, Wallace DJ.
    Lupus; 2001; 10(7):480-3. PubMed ID: 11480845
    [Abstract] [Full Text] [Related]

  • 2. Double-blind, randomized, placebo-controlled pilot study of leflunomide in systemic lupus erythematosus.
    Tam LS, Li EK, Wong CK, Lam CW, Szeto CC.
    Lupus; 2004; 13(8):601-4. PubMed ID: 15462490
    [Abstract] [Full Text] [Related]

  • 3. Combination leflunomide and methotrexate (MTX) therapy for patients with active rheumatoid arthritis failing MTX monotherapy: open-label extension of a randomized, double-blind, placebo controlled trial.
    Kremer J, Genovese M, Cannon GW, Caldwell J, Cush J, Furst DE, Luggen M, Keystone E, Bathon J, Kavanaugh A, Ruderman E, Coleman P, Curtis D, Kopp E, Kantor S, Weisman M, Waltuck J, Lindsley HB, Markenson J, Crawford B, Fernando I, Simpson K, Strand V.
    J Rheumatol; 2004 Aug; 31(8):1521-31. PubMed ID: 15290730
    [Abstract] [Full Text] [Related]

  • 4. Safety and efficacy of leflunomide in primary Sjögren's syndrome: a phase II pilot study.
    van Woerkom JM, Kruize AA, Geenen R, van Roon EN, Goldschmeding R, Verstappen SM, van Roon JA, Bijlsma JW.
    Ann Rheum Dis; 2007 Aug; 66(8):1026-32. PubMed ID: 17223657
    [Abstract] [Full Text] [Related]

  • 5. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
    Cohen S, Cannon GW, Schiff M, Weaver A, Fox R, Olsen N, Furst D, Sharp J, Moreland L, Caldwell J, Kaine J, Strand V.
    Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
    [Abstract] [Full Text] [Related]

  • 6. Analysis of changes in joint function and peripheral blood mononuclear cells in patients with systemic lupus erythematosus and intervention effects of different drugs.
    Zhou QS, Hu J, Hu H.
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(19):4423-4430. PubMed ID: 29077150
    [Abstract] [Full Text] [Related]

  • 7. Long-term efficacy of leflunomide on disease activity and inhibition of joint damage: retrospective comparison with methotrexate for Japanese rheumatoid arthritis patients.
    Katayama K, Matsuno T.
    Mod Rheumatol; 2009 Oct; 19(5):513-21. PubMed ID: 19603251
    [Abstract] [Full Text] [Related]

  • 8. Methotrexate in patients with moderate systemic lupus erythematosus (exclusion of renal and central nervous system disease).
    Gansauge S, Breitbart A, Rinaldi N, Schwarz-Eywill M.
    Ann Rheum Dis; 1997 Jun; 56(6):382-5. PubMed ID: 9227169
    [Abstract] [Full Text] [Related]

  • 9. [Treatment of severe active systemic lupus erythematosus by PMC therapy combined langchuang fuzheng jiedu capsule: a clinical observation].
    Song XW, Tang WJ, Guan TR, Dai QD, Zhang Y, Wu YJ.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Oct; 33(10):1315-9. PubMed ID: 24432670
    [Abstract] [Full Text] [Related]

  • 10. Controlled trial with chloroquine diphosphate in systemic lupus erythematosus.
    Meinão IM, Sato EI, Andrade LE, Ferraz MB, Atra E.
    Lupus; 1996 Jun; 5(3):237-41. PubMed ID: 8803897
    [Abstract] [Full Text] [Related]

  • 11. Double blind, randomized, placebo controlled clinical trial of methotrexate in systemic lupus erythematosus.
    Carneiro JR, Sato EI.
    J Rheumatol; 1999 Jun; 26(6):1275-9. PubMed ID: 10381042
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of leflunomide in treatment of steroid-dependent and steroid-resistant adult onset minimal change disease.
    Zhou J, Zhang Y, Liu G, Li J, Xu R, Huang J.
    Clin Nephrol; 2013 Aug; 80(2):121-9. PubMed ID: 23458173
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of leflunomide or methotrexate plus subcutaneous tumour necrosis factor-alpha blocking agents in rheumatoid arthritis.
    Benucci M, Saviola G, Baiardi P, Manfredi M, Sarzi-Puttini P, Atzeni F.
    Int J Immunopathol Pharmacol; 2011 Aug; 24(1):269-74. PubMed ID: 21496415
    [Abstract] [Full Text] [Related]

  • 14. Leflunomide is associated with a higher flare rate compared to methotrexate in the treatment of chronic uveitis in juvenile idiopathic arthritis.
    Bichler J, Benseler SM, Krumrey-Langkammerer M, Haas JP, Hügle B.
    Scand J Rheumatol; 2015 Aug; 44(4):280-3. PubMed ID: 25993023
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of methotrexate in articular and cutaneous manifestations of systemic lupus erythematosus.
    Islam MN, Hossain M, Haq SA, Alam MN, Ten Klooster PM, Rasker JJ.
    Int J Rheum Dis; 2012 Feb; 15(1):62-8. PubMed ID: 22324948
    [Abstract] [Full Text] [Related]

  • 16. The SMILE study -- safety of methotrexate in combination with leflunomide in rheumatoid arthritis.
    Bird P, Griffiths H, Tymms K, Nicholls D, Roberts L, Arnold M, Burnet S, de Jager J, Scott J, Zochling J, Littlejohn G.
    J Rheumatol; 2013 Mar; 40(3):228-35. PubMed ID: 23322457
    [Abstract] [Full Text] [Related]

  • 17. Leflunomide: friend or foe for systemic lupus erythematosus?
    Wu GC, Xu XD, Huang Q, Wu H.
    Rheumatol Int; 2013 Feb; 33(2):273-6. PubMed ID: 22961090
    [Abstract] [Full Text] [Related]

  • 18. A longterm prospective real-life experience with leflunomide in juvenile idiopathic arthritis.
    Alcântara AC, Leite CA, Leite AC, Sidrim JJ, Silva FS, Rocha FA.
    J Rheumatol; 2014 Feb; 41(2):338-44. PubMed ID: 24334641
    [Abstract] [Full Text] [Related]

  • 19. Comparative effectiveness of rituximab in combination with either methotrexate or leflunomide in the treatment of rheumatoid arthritis.
    Narváez J, Díaz-Torné C, Ruiz JM, Hernández MV, Torrente-Segarra V, Ros S, Rodriguez de la Serna A, Díaz-López C, Sanmartí R, Nolla JM.
    Semin Arthritis Rheum; 2011 Dec; 41(3):401-5. PubMed ID: 21862107
    [Abstract] [Full Text] [Related]

  • 20. Bromocriptine in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled study.
    Alvarez-Nemegyei J, Cobarrubias-Cobos A, Escalante-Triay F, Sosa-Muñoz J, Miranda JM, Jara LJ.
    Lupus; 1998 Dec; 7(6):414-9. PubMed ID: 9736326
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.